Aquestive 制药 AQST
$3.61 −$0.05 (-1.37%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.60 -0.28%
开盘$3.71
昨收$3.66
当日区间$3.55 – $3.76
成交量4.14M
市值$453.73M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$13.82M+38.1% YoY
营业利润-$8.22M+27.7% YoY
净利润-$22.86M-68.8% YoY
摊薄每股收益-$0.18-28.6% YoY
自由现金流-$9.65M-20.3% YoY
经营现金流-$9.44M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率67.0%
营业利润率-97.5%
净利率-144.6%
资产收益率-69.3%
流动比率7.19
负债/资产比率142.8%
现金及投资$98.49M
总负债$58.21M
净现金（净负债）$40.28M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $13.82M | $14.45M | $44.55M | $13.02M | $12.81M |
| 营业总收入 | $13.82M | $14.45M | $44.55M | $13.02M | $12.81M |
| 营业成本 | $4.02M | $3.47M | $18.56M | $5.84M | $4.51M |
| 毛利润 | $9.80M | $10.98M | $25.99M | $7.18M | $8.30M |
| 营业费用 | $18.03M | $15.18M | $97.04M | $36.02M | $19.78M |
| 销售及管理费用 | $14.06M | $10.98M | $79.85M | $32.82M | $15.25M |
| 研发费用 | $3.96M | $4.20M | $17.19M | $3.20M | $4.53M |
| 营业利润 | -$8.22M | -$4.20M | -$71.05M | -$28.84M | -$11.48M |
| 非经营性利息净收入（支出） | -$2.96M | -$3.85M | -$12.73M | -$3.02M | -$3.97M |
| 非经营性利息收入 | $882,000.00 | $83,000.00 | $4.37M | $1.25M | $306,000.00 |
| 非经营性利息支出 | $3.84M | $3.94M | $17.10M | $4.27M | $4.27M |
| 其他收入（支出） | -$11.68M | – | – | – | – |
| 特殊收益（费用） | -$11.68M | – | – | – | – |
| -减：其他特殊支出 | $11.68M | – | – | – | – |
| 税前利润 | -$22.86M | -$8.06M | -$83.78M | -$31.86M | -$15.45M |
| 净利润 | -$22.86M | -$8.06M | -$83.78M | -$31.86M | -$15.45M |
| 持续经营利润 | -$22.86M | -$8.06M | -$83.78M | -$31.86M | -$15.45M |
| 归属母公司净利润 | -$22.86M | -$8.06M | -$83.78M | -$31.86M | -$15.45M |
| 归属普通股股东净利润 | -$22.86M | -$8.06M | -$83.78M | -$31.86M | -$15.45M |
| 基本每股收益 | -$0.18 | -$0.07 | -$0.78 | -$0.26 | -$0.14 |
| 摊薄每股收益 | -$0.18 | -$0.07 | -$0.78 | -$0.26 | -$0.14 |
| 税费 | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $132.10M | $141.13M | $160.43M | $160.43M | $163.56M |
| 流动资产合计 | $118.49M | $130.18M | $149.27M | $149.27M | $151.67M |
| 现金及现金等价物与短期投资 | $98.49M | $110.73M | $121.17M | $121.17M | $129.06M |
| -现金及现金等价物 | $98.49M | $110.73M | $121.17M | $121.17M | $129.06M |
| 应收款 | $9.33M | $6.87M | $17.76M | $17.76M | $11.80M |
| -应收账款 | $7.72M | $5.26M | $8.01M | $8.01M | $9.48M |
| -其他应收款 | $1.61M | $1.61M | $10.33M | $10.33M | $2.32M |
| -应收款调整准备 | $0.00 | $0.00 | -$582,000.00 | -$582,000.00 | $0.00 |
| 存货 | $7.37M | $8.07M | $6.17M | $6.17M | $7.88M |
| 其他流动资产 | $3.31M | $4.52M | $4.17M | $4.17M | $2.93M |
| 非流动资产合计 | $13.61M | $10.94M | $11.16M | $11.16M | $11.89M |
| 固定资产净值 | $11.91M | $8.31M | $8.51M | $8.51M | $8.69M |
| -固定资产原值 | $56.17M | $52.43M | $52.54M | $52.54M | $52.59M |
| -累计折旧 | -$44.26M | -$44.13M | -$44.02M | -$44.02M | -$43.90M |
| 一年以上应收账款 | $1.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| 其他非流动资产 | $701,000.00 | $635,000.00 | $642,000.00 | $642,000.00 | $1.20M |
| 负债合计 | $188.69M | $175.18M | $194.09M | $194.09M | $167.67M |
| 流动负债合计 | $16.48M | $31.75M | $47.61M | $47.61M | $25.57M |
| 应付款 | $9.29M | $12.30M | $30.21M | $30.21M | $11.28M |
| -应付账款 | $8.97M | $11.89M | $29.86M | $29.86M | $10.87M |
| -应付税款合计 | $328,000.00 | $408,000.00 | $349,000.00 | $349,000.00 | $410,000.00 |
| 一年内应计费用 | $968,000.00 | $972,000.00 | $973,000.00 | $973,000.00 | $1.02M |
| 短期债务及融资租赁负债 | $852,000.00 | $14.32M | $10.63M | $10.63M | $6.93M |
| -一年内到期债务 | $32,000.00 | $13.66M | $9.99M | $9.99M | $6.33M |
| -一年内到期融资租赁负债 | $820,000.00 | $662,000.00 | $631,000.00 | $631,000.00 | $601,000.00 |
| 一年内递延负债 | $1.09M | $1.09M | $1.09M | $1.09M | $1.09M |
| 其他流动负债 | $1.05M | $1.00M | $1.00M | $1.00M | $1.56M |
| 非流动负债合计 | $172.21M | $143.43M | $146.48M | $146.48M | $142.09M |
| 长期债务及融资租赁负债 | $58.18M | $29.26M | $31.86M | $31.86M | $34.45M |
| -长期债务 | $50.65M | $25.10M | $27.52M | $27.52M | $29.94M |
| -长期融资租赁负债 | $7.53M | $4.16M | $4.34M | $4.34M | $4.51M |
| 一年以上递延负债 | $18.85M | $19.12M | $19.39M | $19.39M | $19.66M |
| 其他非流动负债 | $34.02M | $32.97M | $33.21M | $33.21M | $26.01M |
| 股东权益合计 | -$56.59M | -$34.05M | -$33.66M | -$33.66M | -$4.11M |
| 股东权益 | -$56.59M | -$34.05M | -$33.66M | -$33.66M | -$4.11M |
| 股本 | $126,000.00 | $124,000.00 | $122,000.00 | $122,000.00 | $121,000.00 |
| -普通股 | $126,000.00 | $124,000.00 | $122,000.00 | $122,000.00 | $121,000.00 |
| 资本公积 | $421.21M | $420.88M | $413.21M | $413.21M | $410.91M |
| 留存收益 | -$477.92M | -$455.06M | -$447.00M | -$447.00M | -$415.14M |
| 商誉及其他无形资产 | – | – | – | – | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$9.44M | -$14.81M | -$52.43M | -$8.47M | -$12.65M |
| 持续经营经营活动现金流净额 | -$9.44M | -$14.81M | -$52.43M | -$8.47M | -$12.65M |
| 持续经营净利润 | -$22.86M | -$8.06M | -$83.78M | -$31.86M | -$15.45M |
| 折旧、折耗与摊销 | $136,000.00 | $113,000.00 | $548,000.00 | $130,000.00 | $139,000.00 |
| 其他非现金项目 | $1.81M | $3.21M | $11.00M | $2.75M | $2.76M |
| 营运资金变动 | -$3.10M | -$12.39M | $12.18M | $19.14M | -$2.88M |
| -应收款变动 | -$2.46M | $10.90M | -$10.37M | -$5.96M | $63,000.00 |
| -存货变动 | $706,000.00 | -$1.90M | -$126,000.00 | $1.71M | $241,000.00 |
| -预付资产变动 | $2.14M | -$340,000.00 | $698,000.00 | -$685,000.00 | -$1.72M |
| -应付账款及应计费用变动 | -$3.21M | -$20.78M | $22.56M | $24.34M | -$1.19M |
| -其他营运资金变动 | -$273,000.00 | -$272,000.00 | -$571,000.00 | -$272,000.00 | -$273,000.00 |
| 投资活动现金流净额 | -$212,000.00 | -$52,000.00 | -$562,000.00 | -$85,000.00 | -$235,000.00 |
| 持续经营投资活动现金流净额 | -$212,000.00 | -$52,000.00 | -$562,000.00 | -$85,000.00 | -$235,000.00 |
| 资本支出 | -$212,000.00 | -$52,000.00 | -$562,000.00 | -$85,000.00 | -$235,000.00 |
| 筹资活动现金流 | -$2.59M | $4.42M | $102.62M | $660,000.00 | $81.41M |
| 持续经营筹资活动现金流净额 | -$2.59M | $4.42M | $102.62M | $660,000.00 | $81.41M |
| 债务发行及偿还净额 | $5.44M | -$8,000.00 | -$26,000.00 | -$5,000.00 | -$7,000.00 |
| 普通股发行净额 | -$79,000.00 | $4.76M | $100.65M | -$301,000.00 | $79.72M |
| 股票期权行使所得 | $759,000.00 | $1,000.00 | $2.81M | $984,000.00 | $1.77M |
| 其他筹资费用净额 | -$8.71M | -$329,000.00 | -$821,000.00 | -$18,000.00 | -$70,000.00 |
| 期末现金余额 | $98.49M | $110.73M | $121.17M | $121.17M | $129.06M |
| 现金净变动 | -$12.24M | -$10.44M | $49.62M | -$7.89M | $68.53M |
| 期初现金余额 | $110.73M | $121.17M | $71.55M | $129.06M | $60.54M |
| 自由现金流 | -$9.65M | -$14.86M | -$52.99M | -$8.55M | -$12.88M |
暂无评论——快来第一个聊聊 AQST。
登录后参与讨论。